It's coming anytime. From most recent pr:
"We have advanced according to plan in the clinical, chemistry, regulatory, and intellectual property areas of KIT-302's development," remarked Kitov's CEO, Isaac Israel. "We are on track to submit our NDA for KIT-302 anticipated for the end of 2016. We are committed to extending our pipeline of drugs with cutting edge technologies, and to continue securing the intellectual property rights over our proprietary assets in order to maximize value to our shareholders."
Ps. I also thought this hinted at acquisition coming: "We are committed to extending our pipeline of drugs with cutting edge technologies"